Developer of a digital therapy platform (DTP) designed to empower clinicians to deliver best practices. neurocare is based in Munich, Germany and was founded in 2014. Its last known valuation is $75.8 million (Jan 2024). It has raised $20 million.
Last price · $/share
—
Implied valuation
$75.8M
Total raised
$20.0M
Last round
—
Cap table — not yet on record
neurocare's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of neurocare with a free account
·The complete investor list: 13 names
·Watch neurocare: the Monday email on marks, rounds and moves
